Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This study has been designed as a randomized, double blinded, multi-centric, placebo controlled, and phase II dose-ranging study. The herbal drug contains bioactive ingredients from Labisia pumila plant and it is an aqueous ethanolic standardized extract (SKF7™).
Description: Percentage of subjects whose Body Weight is lowered
Measure: Change in body weight Time: 12 weeksDescription: Change in waist and hip circumference
Measure: Change in waist and hip circumferences Time: 12 weeksDescription: Change in waist-hip ratio and waist-height ratio
Measure: Change in the waist-hip and waist-height ratios Time: 12 weeksDescription: Change in BMI in kg/m^2
Measure: Change in Body Mass Index (BMI) Time: 12 weeksDescription: The change of body fat percentage
Measure: Body fat percentage Time: 12 weeksDescription: The amount of lean body mass will be calculated from body fat percentage
Measure: Lean Body Mass Time: 12 weeksDescription: Abnormality of vital signs and laboratory test results
Measure: Incidence of abnormal vital signs and of abnormal laboratory test results Time: 12 weeksDescription: The incidence and percentage of Adverse events and serious adverse events
Measure: Incidence of Adverse Events Time: 12 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports